Silent InHERitance explores the power of breaking the silence around ovarian cancer through the stories of women, their families, and the risks they carry. The campaign highlights how starting a conversation can be the first step toward awareness, prevention, and change.

Attending ASCO 2026 underscored both the meaningful progress in gynecologic cancer care and the urgent need for greater awareness. For many women in mid-life, menopause symptoms can mirror early warning signs of cancer—often leading to delayed diagnoses in the absence of reliable screening options.

A powerful look at how silence, stigma, and unspoken family history have shaped hereditary ovarian cancer—and how InHERitance is changing the conversation through storytelling, advocacy, and prevention.